BVS
Price
$7.39
Change
+$0.07 (+0.96%)
Updated
Aug 20, 02:17 PM (EDT)
Capitalization
489.65M
83 days until earnings call
WUXAY
Price
$12.86
Change
-$0.71 (-5.23%)
Updated
Aug 19 closing price
Capitalization
37.26B
Interact to see
Advertisement

BVS vs WUXAY

Header iconBVS vs WUXAY Comparison
Open Charts BVS vs WUXAYBanner chart's image
Bioventus
Price$7.39
Change+$0.07 (+0.96%)
Volume$300
Capitalization489.65M
Wuxi Apptec
Price$12.86
Change-$0.71 (-5.23%)
Volume$9.06K
Capitalization37.26B
BVS vs WUXAY Comparison Chart in %
Loading...
BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WUXAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVS vs. WUXAY commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVS is a StrongBuy and WUXAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 20, 2025
Stock price -- (BVS: $7.32 vs. WUXAY: $12.86)
Brand notoriety: BVS and WUXAY are both not notable
BVS represents the Medical/Nursing Services, while WUXAY is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BVS: 127% vs. WUXAY: 133%
Market capitalization -- BVS: $489.65M vs. WUXAY: $37.26B
BVS [@Medical/Nursing Services] is valued at $489.65M. WUXAY’s [@Medical Specialties] market capitalization is $37.26B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.44B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.59B. The average market capitalization across the [@Medical Specialties] industry is $10.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVS’s FA Score shows that 0 FA rating(s) are green whileWUXAY’s FA Score has 2 green FA rating(s).

  • BVS’s FA Score: 0 green, 5 red.
  • WUXAY’s FA Score: 2 green, 3 red.
According to our system of comparison, WUXAY is a better buy in the long-term than BVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVS’s TA Score shows that 5 TA indicator(s) are bullish while WUXAY’s TA Score has 3 bullish TA indicator(s).

  • BVS’s TA Score: 5 bullish, 4 bearish.
  • WUXAY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BVS is a better buy in the short-term than WUXAY.

Price Growth

BVS (@Medical/Nursing Services) experienced а +0.14% price change this week, while WUXAY (@Medical Specialties) price change was +0.47% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.26%. For the same industry, the average monthly price growth was +0.45%, and the average quarterly price growth was +3.71%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.65%. For the same industry, the average monthly price growth was +11.39%, and the average quarterly price growth was +3.05%.

Reported Earning Dates

BVS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.26% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (+2.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WUXAY($37.3B) has a higher market cap than BVS($490M). BVS has higher P/E ratio than WUXAY: BVS (244.00) vs WUXAY (19.24). WUXAY YTD gains are higher at: 87.318 vs. BVS (-30.286). WUXAY has higher annual earnings (EBITDA): 19.8B vs. BVS (86.9M). WUXAY has more cash in the bank: 24.4B vs. BVS (32.9M). BVS has less debt than WUXAY: BVS (341M) vs WUXAY (7.52B). WUXAY has higher revenues than BVS: WUXAY (42.8B) vs BVS (564M).
BVSWUXAYBVS / WUXAY
Capitalization490M37.3B1%
EBITDA86.9M19.8B0%
Gain YTD-30.28687.318-35%
P/E Ratio244.0019.241,268%
Revenue564M42.8B1%
Total Cash32.9M24.4B0%
Total Debt341M7.52B5%
TECHNICAL ANALYSIS
Technical Analysis
BVSWUXAY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 17 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WUXAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ENHRX10.490.05
+0.48%
Cullen Enhanced Equity Income Retail
NFJEX10.68N/A
N/A
Virtus NFJ Dividend Value Inst
FRIOX11.85N/A
N/A
Fidelity Advisor Real Estate Income C
MXIVX15.55N/A
N/A
Empower International Value Inv
UIVCX12.66N/A
N/A
MFS Intrinsic Value C

WUXAY and

Correlation & Price change

A.I.dvisor tells us that WUXAY and QDEL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WUXAY and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WUXAY
1D Price
Change %
WUXAY100%
-5.23%
QDEL - WUXAY
22%
Poorly correlated
+3.58%
MOVE - WUXAY
9%
Poorly correlated
-3.83%
LNSR - WUXAY
4%
Poorly correlated
-1.96%
BVS - WUXAY
3%
Poorly correlated
+1.95%
KSRBF - WUXAY
3%
Poorly correlated
N/A
More